Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dihydropyrimidine dehydrogenase (DPD) polymorphisms knocking on the door. | Ecancermedicalscience | 2022 | 35242225 | PubTator, text mining | PubMed |
| Impact of histological subtype on prognosis in stage IV colorectal cancer: A population-based cohort study. | PLoS One | 2022 | 35239725 | PubTator, text mining | PubMed |
| Survey of US Medical Oncologists' Practices and Beliefs Regarding DPYD Testing Before Fluoropyrimidine Chemotherapy. | JCO Oncol Pract | 2022 | 35239419 | PubTator, text mining | PubMed |
| Precision medicine for metastatic colorectal cancer in clinical practice. | Ther Adv Med Oncol | 2022 | 35237350 | PubTator, text mining | PubMed |
| Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer: A Randomized Clinical Trial. | JAMA Netw Open | 2022 | 35226081 | PubTator, text mining | PubMed |
| Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil. | ACS Omega | 2022 | 35224365 | PubTator, text mining | PubMed |
| SWAAT Bioinformatics Workflow for Protein Structure-Based Annotation of ADME Gene Variants. | J Pers Med | 2022 | 35207751 | PubTator, text mining | PubMed |
| Elevated Risk of Fluoropyrimidine-Associated Toxicity in European Patients with DPYD Genetic Polymorphism: A Systematic Review and Meta-Analysis. | J Pers Med | 2022 | 35207713 | PubTator, text mining | PubMed |
| Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study. | J Pers Med | 2022 | 35207692 | PubTator, text mining | PubMed |
| Pharmacogenetics to Avoid Adverse Drug Reactions. | J Pers Med | 2022 | 35207648 | PubTator, text mining | PubMed |
| Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data. | J Pers Med | 2022 | 35207616 | PubTator, text mining | PubMed |
| Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma. | Cancers (Basel) | 2022 | 35205743 | PubTator, text mining | PubMed |
| Pharmacogenetics of Drugs Used in the Treatment of Cancers. | Genes (Basel) | 2022 | 35205356 | PubTator, text mining | PubMed |
| Upfront DPYD Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress. | Curr Oncol | 2022 | 35200545 | PubTator, text mining | PubMed |
| Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder. | Pharmacogenomics J | 2022 | 35197553 | PubTator, text mining | PubMed |
| Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review. | Pharmacogenomics J | 2022 | 35194175 | PubTator, text mining | PubMed |
| Delineation of the molecular mechanisms underlying Colistin-mediated toxicity using metabolomic and transcriptomic analyses. | Toxicol Appl Pharmacol | 2022 | 35189178 | PubTator, text mining | PubMed |
| Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis. | Elife | 2022 | 35188460 | PubTator, text mining | PubMed |
| Long-Term Survival Following Palliative Chemoradiotherapy in an Elderly Patient With Advanced Squamous Cell Carcinoma in the Right Mandibular Gingiva. | Cureus | 2022 | 35186607 | PubTator, text mining | PubMed |
| Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data. | NPJ Genom Med | 2022 | 35181665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=48